patent evaluation Resources | BNET
On The Insider: Nikki Blonsky 'Living in Pain'

Resources

1 Resources for

patent evaluation

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Patent Evaluation Goes Public
Inventions today are more complicated than ever, which makes it hard to judge the quality of new patents and relatively easy to get protection for half-baked ideas. Sooner or later, those half-baked inventions become the subject of bank-breaking litigation, and the U.S. Supreme Court recently said that needs to stop....
Tags: Litigation, Business Operations, Andrew Hines, Scrutiny Idea, Patent Evaluation, U.S. Patent And Trademark Office, Patent Office, Patent
Blog posts 2007-06-06

Additional Resources

Wi-LAN Litigation Update
Wi-LAN Inc. ("Wi-LAN" or the "Company") (TSX: WIN), a leading technology innovation and licensing company, today provided a litigation update. Wi-LAN believes that Intel Corporation ("Intel") has filed a claim against Wi-LAN in the Northern District of California requesting a declaratory judgment that 18 of Wi-LAN's U.S. patents are invalid...
Articles 2008-10-01
Lotus Pharmaceuticals, Inc.'s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
BEIJING, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (BULLETIN BOARD: LTUS) ("Lotus" or the "Company"), a pharmaceutical products developer, manufacturer and distributor in the People's Republic of China ("PRC"), today announced that China's State Food and Drug Administration SFDA is evaluating the Company's drug Laevo-Bambutero for clinical trials....
Articles 2008-09-25
Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
First Such Board on the Market, Stantum's SMK Series Will Let Vendors Cost-Effectively Develop Their Own Resistive Multi-Touch Applications SAN DIEGO, Sept. 23 /PRNewswire/ -- Stantum Technologies (http://www.stantum.com/), a pioneer developer of multi-touch sensing technology, today introduced a demo, evaluation and development board based on its patented...
Articles 2008-09-23
The Pressure Pipe Inspection Company purchases International Rights to the Sahara ® Leak location system from WRC plc
TORONTO, Sept. 18 /PRNewswire/ -- The Pressure Pipe Inspection Company PPIC, a leader in water pipe infrastructure inspection technologies, has announced that it has purchased the international rights to the Sahara Leak Location System. PPIC has been the exclusive licensee of the Sahara R system in North American and...
Articles 2008-09-18
Study confirms safety of Super CitriMax
Super CitriMax, InterHealth Nutraceuticals' patented calcium/potassium (-)hydroxycitric acid weight management ingredient, was shown to have no toxic effects in a two-generation reproduction study. The results, published in Toxicology Mechanisms and Methods, further affirms the long-term safety of this diet ingredient. The study evaluated the effects of Super CitriMax...
Articles 2008-09-01
NSF International
NSF International has certified the purity of four products from Mannatech Inc. Coppell, TX, NSF evaluated the capsule and powder versions of the Ambrotose and Advanced Ambrotose supplements, which contain a patented blend of plant-sourced saccharides.The products were certified according to the NSF/ANSI 173 Dietary Supplement Standard. Mannatech is working...
Articles 2008-09-01
Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
Sinobiomed Inc. ("Sinobiomed", or "the Company") (OTCBB: SOBM) is pleased to announce that it has retained CB Capital Partners, Inc. as its financial advisor to evaluate strategic alternatives to maximize shareholder value. "While we are extremely pleased with the results obtained from the work undertaken to date on our three...
Articles 2008-08-26
Research and Markets: The Essential EvaluatePharma® Yearbook with Company Performance Tables for 150 Companies: Detailing Growth, Patent Expiry and Expenditure
DUBLIN, Ireland -- Research and Markets http://www.researchandmarkets.com/research/123227/evaluatepharma[R]_ye has announced the addition of the "EvaluatePharma[R] Yearbook - Company Performance Tables" report to their offering. Benchmark a Changing Market In a fast-changing pharmaceutical market it is vital to be able to measure company performance easily and accurately -...
Articles 2008-08-19
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
EAST SETAUKET, N.Y., Aug. 19 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (BULLETIN BOARD: LIXT) announced today that the National Institute of Neurological Disorders and Stroke NINDS, National Institutes of Health NIH and Lixte filed a joint patent application identifying a biomarker, present in many common cancers, that...
Articles 2008-08-19
PrismaStar® Debuts Next-Generation Camera Selector at Mology.com
Revolutionary Product Search Tool is World's First to Mimic Human Decision Making CHICAGO, Aug. 19 /PRNewswire/ -- PrismaStar Software, dedicated to helping consumers make Better, Faster Decisions, announced today the US debut of the MologyTM camera selector (http://www.mology.com/). The Mology Website is powered by AnswerOilR, an...
Articles 2008-08-19
IpAuctions Selling Click-2-Call Internet Patent Portfolio
RENO, Nev. -- IpAuctions, Inc. will auction the worldwide portfolio of U.S. patents in the "click-2-call" space owned by Click Interconnect Inc. CLICK of Fort Lauderdale, Fla. Ernesto Liebster, president of CLICK, currently is evaluating proposals for exclusive licensing rights that CLICK could accept prior to the auction date, September...
Articles 2008-08-18
ZIOPHARM Receives Notices of Allowance for European and U.S. Patents Covering Indibulin
NEW YORK -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it has received notice from the European Patent Office that it intends to grant a patent with claims covering certain pharmaceutical formulations of indibulin (ZIO-301) for oral administration and processes for manufacturing such formulations. The Company also announced that...
Articles 2008-08-18
Roche poised to take over industry lead
LONDON -- Roche Holding AG may become the top drug manufacturer in the world by 2014 as Pfizer Inc. and Eli Lilly and Co. slip in the rankings due to expiring patents, according to one industry consultant. Roche may command 6% of global prescription drug sales in 2014,...
Articles 2008-08-18
Meda: Registration Application for Azelastine Extra Strength Submitted to the FDA
STOCKHOLM, Sweden -- Regulatory News: Meda AB (STO:MEDAA): The registration application for azelastine nasal spray in the new formulation with Extra Strength has been submitted to the US Food and Drug Administration FDA, seeking approval to treat symptoms of Seasonal Allergic Rhinitis and Perennial Allergic Rhinitis....
Articles 2008-08-04
The Overall Prescription Pharmaceutical Market for Monoclonal Antibodies Is Expected To Face a Decline in Sales Over 2011 To 2012 As A Result Of the Patent Cliff
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/107178/monoclonal_antibod) has announced the addition of the "Monoclonal Antibodies Report: 2008 Update " report to their offering. Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2013, evaluating the strategies companies are...
Articles 2008-08-01
OREXIGEN® Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
OREX-003 Being Developed as an Antipsychotic Agent with Less Potential for Treatment-Associated Weight Gain and Metabolic Risks SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- OrexigenR Therapeutics, Inc. today announced that the United States Patent and Trademark Office USPTO issued a Notice of Allowance for a patent application...
Articles 2008-07-29
Research and Markets: Injectable Generic Drugs: Prospects & Opportunities to 2013
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/9d0b85/injectable_generic) has announced the addition of the "Injectable Generic Drugs: Prospects & Opportunities to 2013" report to their offering. This report provides: * Individual analysis of 48 leading therapies * Product forecasts by value 2008/2013 *...
Articles 2008-07-25
NOVARTIS ACQUIRING ADDITIONAL SHARES OF SPEEDEL FROM FIVE SIGNIFICANT SPEEDEL SHAREHOLDERS
Basel/Switzerland and Bridgewater NJ/USA, 10 July 2008 Speedel Holding Ltd. (SWX: SPPN) today announced that yesterdayevening, five major shareholders of Speedel, including Alice Huxley,Chief Executive Officer of Speedel, have informed the Board ofDirectors of Speedel...
Articles 2008-07-10
Frost & Sullivan Lauds Rotrex A/S for its Innovative Products and Dedication to Furthering Engine Boosting Technologies
LONDON -- Based on its recent analysis of the gasoline and diesel engine boosting technologies market, Frost & Sullivan recognises Rotrex A/S with the 2008 European Award for Product Innovation. This is for developing pioneering products for vehicle manufacturers as well as working with them to downsize...
Articles 2008-07-09
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement